Stimulant Withdrawal
A condition involving a characteristic withdrawal syndrome that develops after stopping or significantly reducing prolonged stimulant use.
Overview
Stimulant withdrawal involves the development of a characteristic set of symptoms within hours to several days after stopping or significantly reducing prolonged stimulant use, such as amphetamine-type substances or cocaine.
Signs and Symptoms
Symptoms can include fatigue, vivid unpleasant dreams, increased appetite, sleep disturbance, and depressed mood, sometimes with intense cravings. Experiencing one or more of these symptoms does not necessarily mean that a person has this condition. Diagnosis requires an appropriate clinical evaluation.
Causes and Risk Factors
Stimulant withdrawal results from the body’s adaptation to regular stimulant use and the drop in stimulant exposure after stopping.
Diagnosis
A diagnosis should be made by a qualified healthcare professional following a comprehensive clinical assessment. Clinicians may use established diagnostic frameworks such as DSM-5-TR and/or ICD-11 as part of a comprehensive assessment.
Treatment
Treatment depends on the individual’s symptoms, clinical history, severity, age, co-occurring conditions, and other relevant factors.
Psychotherapy
Behavioral support during withdrawal, along with structured treatment for the underlying use disorder, improves outcomes.
Living With Stimulant Withdrawal
Depressed mood during stimulant withdrawal can be significant; monitoring for safety and connecting with treatment support is important during this period.
When to Seek Professional Help
Professional evaluation may be appropriate if symptoms persist, worsen, cause significant distress, or interfere with work, school, or relationships.
Emergency Situations
If a person may be in immediate danger, is experiencing a medical or psychiatric emergency, or may harm themselves or another person, seek immediate assistance through appropriate local emergency services.
Outlook
Acute withdrawal symptoms typically improve within one to two weeks, though mood symptoms and cravings can persist longer.
Related Conditions
Medical Information Disclaimer
Ratel Health provides general educational information and does not provide medical diagnosis, treatment, or individualized medical advice. Information on this page is not a substitute for evaluation or care from a qualified healthcare professional. Do not use this information to diagnose yourself or another person, or to start, stop, or change treatment or medication without consulting an appropriately qualified healthcare professional.
References
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR).
- National Institute of Mental Health.
- U.S. Food and Drug Administration.
- World Health Organization. International Classification of Diseases, 11th Revision.